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Summary: Over the past few years, the transcription factor nuclear
factor (NF)-kB and the proteins that regulate it have emerged as a
signaling system of pre-eminent importance in human physiology and
in an increasing number of pathologies. While NF-kB is present in all
differentiated cell types, its discovery and early characterization were
rooted in understanding B-cell biology. Significant research efforts over
two decades have yielded a large body of literature devoted to under-
standing NF-kB’s functioning in the immune system. NF-kB has been
found to play roles in many different compartments of the immune
system during differentiation of immune cells and development of
lymphoid organs and during immune activation. NF-kB is the nuclear
effector of signaling pathways emanating from many receptors, including
those of the inflammatory tumor necrosis factor and Toll-like receptor
superfamilies. With this review, we hope to provide historical context
and summarize the diverse physiological functions of NF-kB in the
immune system before focusing on recent advances in elucidating the
molecular mechanisms that mediate cell type-specific and stimulus-
specific functions of this pleiotropic signaling system. Understanding
the genetic regulatory circuitry of NF-kB functionalities involves
system-wide measurements, biophysical studies, and computational
modeling.
Introduction: a short historical perspective
Nuclear factor (NF)-kB was discovered biochemically as a
DNA-binding activity in activated B cells, with affinity for
the transcriptional enhancer of the immunoglobulin k light-
chain gene (1). Induction of the activity was correlated with
expression of antibody, suggesting that NF-kB would be an
important regulator of antibody production. However, recent
knockout and knock-in mouse studies have not substantiated
this notion: B cells derived from a variety of NF-kB knockout
mice are able to produce k light-chain-containing antibodies,
as are mice in which the kB consensus sequence site in the k
light-chain enhancer has been mutated. In fact, while the
name NF-kB remains, none of the information it implies is
fully correct. As mentioned, NF-kB is neither a critical reg-
ulator of the k light-chain gene, nor is it B-cell specific, nor
truly a nuclear factor. In fact, NF-kB is present in all cell types,
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its nuclear-cytoplasmic localization is intricately controlled,
and it regulates a large number of genes that control diverse
cellular responses. NF-kB turned out to be a stimulus-respon-
sive pleiotropic regulator of gene control (2).
Induction of NF-kB activity was found not to require pro-
tein synthesis (3, 4), thereby inaugurating a research field
devoted to the elucidation of the pathways that allow for
receptor-specific signal transduction that culminates in nuclear
NF-kB activity. First, experiments distinguished between two
mechanisms: a precursor processing mechanism or regulation
by a separate inhibitor protein. The detergent deoxycholate
was shown to liberate fully active kB-site DNA-binding activ-
ity in unstimulated cells (5), suggesting the existence of
inhibitor proteins, termed IkB (6). Biochemical purification
using the same chromatographic media first in the absence
and then in the presence of deoxycholate led to the identifica-
tion of the NF-kB polypeptides p65 and p50 (7, 8), and IkBa
and IkBb (9). The activation mechanism in response to
inflammatory stimuli was soon shown to involve the signal-
induced proteolysis of NF-kB-bound IkB proteins (10).
Following the identification of signal-induced phosphoryla-
tion of specific serines in IkB proteins as a necessary step in
Ikb proteolysis NF-kB activation (11), the responsible IkB
kinase (IKK) was purified (12) and shown to be the primary
regulator of NF-kB activity (13). Indeed, based on a large body
of literature, the activation mechanism of NF-kB is sufficiently
well understood such that a mathematical model recapitulates
the temporal regulation of canonical NF-kB signaling (14).
Other recent work has uncovered a second NF-kB activation
pathway (often called the non-canonical pathway) in mam-
mals and Drosophila that is currently thought not to involve
inhibitor degradation but rather protein precursor processing
(15). While this signaling pathway shares many of the mole-
cular mediators with the canonical pathway, the mechanism
of stimulus-responsive partial proteolysis remains the focus of
active research.
Biochemistry 101 of NF-kB signaling
The molecular constituents
Current knowledge describes the NF-kB-signaling system as
consisting of about a dozen different dimers comprising five
homologous proteins (Fig 1): the classical and ubiquitously
expressed p50 and p65/RelA proteins, which together con-
stitute the primary inflammatory mediators; the cRel (also
termed Rel) protein, which is triggered in the hematopoietic
compartment, and the p52 and RelB polypeptides, which, as a
heterodimer function in the non-canonical NF-kB pathway
that is responsive to non-inflammatory stimuli (15) and
plays a role in activation chemokine genes involved in
Fig. 1. Nuclear factor (NF)-kB and IkB genes, polypeptides, and
dimers. (Left) Five mammalian NF-kB genes give rise to five transcription
factor proteins, RelA, cRel, RelB, p50, and p52, that share the Rel-
homology domain (pale blue box), which is responsible for DNA binding,
dimerization, and association with IkB proteins. RelA and cRel contain
acidic transcriptional activation domains. The proteins p50 and p52 derive
from a proteolytic processing mechanism of precursor proteins p100 and
p105. Their C-terminal portions contain ankyrin repeat domains that are
the hallmark of the three IkB inhibitor proteins IkBa, IkBb, and IkBe.
(Right) Five NF-kB polypeptides can form 15 transcription factors
through homo- and hetero-dimerization. The top four rows show nine
dimers that can function as transcriptional activators, the fifth row indi-
cates dimers lacking transcriptional activation domains, and the bottom
row shows dimers that are not able to bind DNA. In a given cell, a subset
of dimers may be present, depending on the cell type, stage, and con-
ditioning by environmental cues. Generally, RelA dimers are ubiquitously
expressed, but cRel-containing dimers are more highly expressed in
mature lymphoid cells.
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lymphoid organogenesis. All dimers share the ability to bind
to the kB-site consensus sequence and may therefore be
referred to as NF-kB. How different NF-kB isoforms differ
in regards to their biochemical functions and their physiolo-
gical roles continues to be an active focus of current research
and is addressed in more detail below.
Five homologous proteins are known to play functionally
inhibitory roles on the DNA-binding activity of NF-kB and
have been termed IkB proteins (Fig. 1). This family includes
the canonical IkBs IkBa, IkBb, and IkBe, as well as the pre-
cursor proteins p105 and p100, whose C-terminal portions
have also been termed IkBg and IkBd, respectively, and
whose N-terminal portions encode p50 and p52. It remains
unclear whether the precursor proteins p100 and p105 and/or
the C-terminal portions actually function as bona fide IkB pro-
teins (inhibit the activity of a pre-existing dimer and allow for
its activation in response to cellular stimulation). Current
research also continues to address the regulation of synthesis
and degradation of the canonical IkB inhibitors of NF-kB
activity, as well as IkB isoform-specific functions in regard to
subsets of NF-kB dimers or NF-kB-inducing stimuli.
Biophysical studies and X-ray crystallography have pro-
vided insights about the structure of the NF-kB dimerization
and DNA-binding domains and about the interactions with
IkB proteins and with DNA bearing kB-binding sites (Fig. 2).
These initial studies have revealed subtle but functionally
important differences between NF-kB and IkB isoforms and
in the interaction between NF-kB and different kB-site
sequences. Each interaction is characterized by allostery that
suggests molecular specificity mechanisms that are not merely
governed by bivalent affinity rules. For example, the RelB
protein can exist in two very distinct conformational states
p50DD
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Fig. 2. Allostery within the nuclear factor
(NF-kB)-signaling system. (A) NF-kB dimer
conformation is determined by the binding
partner. Ribbon representations of the dimeri-
zation domains of the p50:p50 (left) and
RelB:RelB (right) homodimers. The structures
are different; a large conformational change
determined by the binding partner renders an
‘open’ dimer (left) that can bind DNA or an
intertwined dimer (right) that is unable to bind
DNA. (B) The conformation of NF-kB bound to
DNA is determined by the sequence of the kB
site. The structure of the rel homology regions
(RHR) of p50:RelA bound to Ig-kB DNA
sequence (left). Superimposition of the a-carbon
trace of three structures determined of the
p50:RelA RHR heterodimer bound to three dif-
ferent kB sites [right; Ig-kB, interferon (IFN)b-
kB, and uPA-kB, located in the enhancer/pro-
moters of the immunoglobulin k light chain,
IFN-b and urokinase plasminogen activator
genes, respectively]. This comparison reveals
conformational changes in the protein interac-
tion surfaces of the dimer induced by single base
differences in the sequence of kB-site-binding
element. (C) NF-kB bound to IkB proteins. The
structure of IkBa bound to the p50:RelA
heterodimer (left). The NLS of RelA, which is
unstructured in the absence of IkB proteins,
folds into a helical structure upon binding to
IkBa. The NLS of p50 does not contact IkBa. The
structure of IkBb bound to the RelA homodimer
(right). The NLS of one RelA subunit interacts
with IkBb as that in IkBa-p50:RelA complex.
The second NLS also makes weak contacts with
IkBb. While unbound IkBa is incompletely
folded, within the complex with NF-kB it is fully
folded.
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depending on its dimeric interaction partner (16) (Fig. 2A).
Second, the same NF-kB dimer bound to DNA exhibits
sequence-specific conformations that are distant from the
DNA interaction surface (17) (Fig. 2B). Third, the folding
states of IkB proteins and NF-kB dimers are critically regulated
by their interaction with each other (18). These observations
emphasize the importance of comprehensive biophysical
characterizations of trapped conformations revealed by X-ray
crystallography and of the dynamics of interactions and con-
comitant conformational changes to understand the molecular
basis of specific, distinct, and overlapping functionalities of
the molecular constituents of the NF-kB-signaling system.
Two NF-kB signaling pathways
Two distinct and evolutionarily conserved NF-kB-signaling
pathways have been described (Fig. 3). They are distinguished
by two multiprotein IKK complexes that regulate the stimulus-
responsive degradation of IkB proteins. The so-called ‘cano-
nical’ IKK complex contains the IKK2 (IKKb) protein and is
regulated by the scaffold protein NF-kB essential modulator
(NEMO, also known as IKKg), whereas the ‘non-canonical’ IKK
complex appears to consist solely of an IKK1 (IKKa) homo-
dimer. Both the so-called canonical and the non-canonical NF-
kB-signaling pathways play important roles in the functioning
of the immune system, yet their roles seem surprisingly dis-
tinct. While the canonical pathway is largely responsible for
regulating inflammation as well as the control of proliferation
and apoptosis of lymphoid cells during the immune response,
the non-canonical pathway is associated with the development
of lymphoid organs that ensure the mounting of an effective
immune response. As described below, the biochemical char-
acteristics of these pathways echo this functional distinction:
the canonical pathway is fast acting (responds within min-
utes) and is reversible due to the presence of multiple negative
feedback mechanisms, whereas the non-canonical pathway
responds more slowly (over hours and days), providing
long-lasting nuclear NF-kB activity.
The canonical NF-kB-signaling pathway
Pro-inflammatory stimuli, such as pathogen-derived lipopoly-
saccharide (LPS) and cytokines such as tumor necrosis factor
(TNF) and interleukin (IL)-1, are strong inducers of NF-kB
activity in many cell types (Fig. 4). The primary NF-kB iso-
form induced by these stimuli is the p50:RelA dimer (also
known as ‘classical NF-kB’), a potent transcriptional activator
of genes regulated by the kB sequence element. The p50:RelA
dimer is present in unstimulated cells, but its DNA-binding
activity is inhibited by IkB. Upon inflammatory stimulation,
the canonical IkB proteins IkBa, IkBb, and IkBe are phos-
phorylated by the canonical IKK complex on two specific N-
terminal serines, which then act as a docking platform for the
ubiquitin ligase b-TRCP. Subsequent ubiquitination (lysine
48-linked chains) induces proteasome-mediated proteolysis
of the IkB protein without affecting the integrity of the
bound NF-kB dimer. Instead, the liberated dimer is capable
of binding DNA and activating genes. While early models
suggested that IkB proteins also inhibit nuclear translocation
of NF-kB dimers, it has become clear that dimers bound to
IkBa and IkBe actively shuttle between nuclear and cytoplas-
mic compartments (19, 20). A key role of the IkB association
Fig. 3. Two nuclear factor (NF)-kB activation pathways. The so-called
canonical NF-kB pathway is triggered by many inflammatory stimuli to
induce IKK2-containing IKK complexes that specifically phosphorylate
the three canonical IkB proteins, thereby marking them for ubiquitina-
tion and proteasome-mediated proteolysis. RelA as well as cRel-
containing dimers are thereby released to translocate to the nucleus and
activate genes. The non-canonical pathway is mediated by IKK1 and
induces the processing of p100 to p52 to release RelB-containing dimers
to the nucleus. Crosstalk between canonical and non-canonical signaling
pathways is of current research interest.
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with NF-kB is therefore its prevention of DNA binding. It has
even been claimed that mutant NF-kB dimers, incapable of
binding DNA, do not fully localize in the nucleus in the
absence of IkB proteins (21). Together, these data point to a
model in which association of IkB with NF-kB may shift the
shuttling behavior of NF-kB quantitatively (i.e. ratio between
nuclear import and export), rather than prevent its nuclear
localization as originally proposed.
Initial activation of canonical NF-kB activity is typically
rapid and does not require de novo protein synthesis. Upon
cell stimulation, increases in nuclear NF-kB activity can be
detected within 10 min, and some NF-kB-responsive
promoters are induced almost immediately. One such early
responding promoter is that of IkBa, which mediates a
powerful negative feedback mechanism that is responsible
for postinduction repression of NF-kB activity upon
stimulus removal (14, 22) and may result in oscillatory NF-
kB activity during chronic stimulation (14, 23). However, the
oscillatory propensity in the signaling system caused by IkBa
is counteracted by a second negative feedback mechanism
mediated by IkBe, which is delayed and functions in
anti-phase to IkBa (24). These insights indicate that cells
have the capacity to intricately modulate the temporal activity
profile of NF-kB and have provided the impetus for current
interest in understanding the potential roles of dynamic con-
trol of NF-kB signaling in stimulus-specific cellular responses
(25).
The non-canonical NF-kB-signaling pathway
Several non-inflammatory stimuli have been shown to engage
the non-canonical NF-kB-signaling pathway in a variety of
cell types. In B cells, the survival factor B-cell-activating factor
belonging to the TNF family (BAFF) (26) and, in splenic
stromal cells, lymphotoxin b signaling (27) were shown to
activate NF-kB activity over a period of many hours or days.
Depending on the stimulus and cell type, this activity consists
of RelB as well as RelA complexed with the dimerization
partners p50 or p52. However, the activation mechanism
remains somewhat unclear. The nfkb2 precursor protein
p100, which is capable of dimerizing with RelB, was origin-
ally shown to undergo partial proteolysis or processing upon
IKK1 stimulation. However, processing itself was shown to be
cotranslational and is thereby restricted to newly synthesized
p100 protein (28). In addition, the mechanism by which
RelA dimers are induced remains unclear. Recent studies
resulted in a simplified model, in which p100 functions as
an IkB protein sequestering both p50 : RelA and p50 : RelB
complexes in resting cells. In this model, stimulation of IKK1
activity leads to full degradation of p100, but newly synthe-
sized p100 is preferentially processed to p52, which dimerizes
with both RelB and RelA to ensure a long-lasting activity of
both RelA- and RelB-containing dimers (S. Basak and A. H.,
unpublished observations).
It is important to note that non-canonical activation of
NF-kB is significantly slower than canonical activation, and
it appears to lack strong negative feedback mechanisms or
highly dynamic control. This finding may in part be explained
by the fact that RelB-containing dimers do not have
high affinities for canonical IkB proteins and are
therefore not subject to their highly dynamic regulation.
Long-lasting steady NF-kB activity may indeed be indicative
of the primary physiological functions of the non-canonical
pathway in cellular differentiation, survival, and
organogenesis.
A B Fig. 4. The IKK-IkB-NF-kB-signaling mod-
ule and temporal control. (A) The canonical
NF-kB pathway represented here by the
so-called IKK-IkB-NF-kB-signaling module
mediates a wide variety extracellular and intra-
cellular signals to control a diverse set of cellular
responses. Negative feedback control mediated
by IkBa and IkBe allows for dynamic regulation
of NF-kB. (B) The Signaling Module receives
input signals in the form of IKK activity profiles.
These are stimulus specifically regulated via
negative feedback mechanisms and autocrine
loops to result in specific dynamics. Each IKK
dynamic profile is transduced by the signaling
module to generate a stimulus-specific NF-kB
activity profile that is critical for stimulus-
specific gene expression.
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Inducers and responsive genes
For largely complete lists of molecules, conditions, genes, and
proteins related to NF-kB regulation, we refer the reader to
www.nf-kb.org, which also indicates a reference for each.
This website is maintained by Tom Gilmore (Boston
University) and has become an increasingly valuable resource.
Below, we characterize each category in broad thematic terms
and provide a conceptual framework.
Hundreds of substances and physiological conditions are
known to activate NF-kB (Fig. 4A). These include (i) bacterial,
fungal, or viral products that are often recognized by the Toll-
like receptor (TLR) pathways; (ii) intercellular signaling med-
iators often recognized by members of the TNF receptor
superfamily; (iii) immunoglobulin domain-containing recep-
tors that regulate the adaptive immune response through the
recognition of free antigen or antigen on antigen-presenting
cells or by mediating intercellular signaling; and (iv) meta-
bolic or genotoxic stress conditions, often induced by envir-
onmental hazards. Such stress conditions may act through
specific signaling mechanisms, such as the stress responsive
kinases ATM/ATR (genotoxic stress), or pleiotropic mechan-
isms, such as translational inhibition (endoplasmic reticulum
stress or the unfolded protein response). While cellular stress
does not activate NF-kB exclusively, NF-kB activation is pro-
minent due to an apparently sensitive balance in resting cells
of synthesis and degradation of IkB proteins, for example.
Such a dynamic equilibrium, or molecular homeostasis,
deserves further study to better understand the molecular
mechanisms and physiological functions of NF-kB activation
by pleiotropic agonists.
Molecular biological studies over the past 20 years have led
to identification of functional kB sites in about a hundred
genes whose induction correlates with NF-kB activation.
These are reflective of NF-kB’s functions in regulating the
communication between cells, regulating cell survival, and
regulating proliferation. Genes encoding inflammatory med-
iators that control cell activation and chemotaxis, such as
the pro-inflammatory cytokines TNF, IL-1, and IL-12 and
chemokines such as monocyte chemotactic protein (MCP)-1,
interferon (IFN)-inducible protein (IP)-10, and RANTES
(regulated upon activation, normal T-cell expressed, and pre-
sumably secreted), are prominent examples whose NF-kB
responsiveness was established long ago. Similarly, NF-kB’s
control of the expression of many of the cognate receptors is
reflective of its major role in tuning the sensitivity of cells to
such extracellular messengers. In addition, large numbers of
NF-kB-dependent genes contribute to the innate immune
response, such as the anti-microbial peptide b-defensin-2 or
the C-reactive protein. Another functionally important cate-
gory is genes that inhibit pro-apoptotic signaling pathways.
They function by interfering with c-Jun N-terminal kinase
signaling [e.g. GADD45b (29)], by preventing the accumula-
tion of reactive oxygen species [e.g. MnSOD, FHC (30)],
maintaining mitochondrial health (Bcl2 family members), or
by targeting directly the caspase cascade [e.g. inhibitors of
apoptosis (31), cellular FLICE inhibitory protein (32)]. In
addition, enzymes involved in tissue remodeling [e.g.
matrix-metalloproteinases (33)] and cell cycle regulatory pro-
teins [e.g. cyclin D (34)] have been reported to be regulated
by NF-kB. Misregulation of these genes due to elevated NF-kB
activity in disease-associated cells appears to play critical roles
in a variety of pathogeneses.
Several more recent studies have aimed at cataloging the
genes that are regulated by NF-kB in a cell type- and stimulus-
specific manner on a genome-wide scale using microarray
technology (35–43). Genetic tools, such as cells derived
from mice deficient in one or several NF-kB subunits or an
ectopically expressed stimulus-unresponsive IkBa mutant pro-
tein (also known as the ‘IkB super-repressor’), have identified
more than 500 genes whose transcriptional regulation
depends on NF-kB. Indeed, it appears that in all the cell
types examined thus far, almost all genes induced by inflam-
matory stimuli are transcriptionally upregulated in an NF-
kB-dependent manner. However, there is little information
about the extent of NF-kB’s role in the regulation of the large
inducible gene expression programs in primary hematopoietic
cells. As such, it remains unclear whether NF-kB dependence is
stimulus- and/or cell type-specific, i.e. genes may be NF-kB-
dependent when induced by inflammatory stimuli but inde-
pendent when induced by non-inflammatory stimuli (or in the
unstimulated cell) or when induced by the same stimulus in a
different cell type. In addition, determination of whether NF-
kB-dependent genes are direct or indirect targets of NF-kB is
an important prerequisite to understanding the NF-kB regula-
tory circuitry that controls gene expression programs.
Interestingly, decreases in the levels of specific mRNAs have
also been observed to involve NF-kB, but in most cases, it
remains unclear whether these are the result of transcriptional
repression or enhanced degradation mechanisms.
As an alternative to genetic/functional studies, chromatin
immunoprecipitation (ChIP) has allowed determination of
physical association of endogenous NF-kB proteins with pro-
moter sequences during inflammatory stimulation. While sin-
gle gene studies have found correlations between NF-kB
dimer recruitment and inducible gene expression, large scale
or genome-wide location analysis (also known as ChIP-chip),
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which is currently in progress, appear to correlate less well
with genetic NF-kB dependence. It remains unclear whether
this discrepancy is due to technical challenges inherent in high
throughput approaches or whether as yet unrecognized reg-
ulatory mechanisms may be the underlying cause. However,
comprehensive location analysis for the RelA/p65 subunit on
chromosome 22 (44) did suggest that NF-kB may be bound
to many chromosomal locations that are not correlated with
gene activity or stimulus responsiveness. Given the complexity
of determining the regulatory networks that determine gene
expression programs, NF-kB is an attractive model system for
genome-wide expression and location analysis, due to its
stimulus-responsiveness and importance to human health.
Inhibitors and interacting proteins
Hundreds of inhibitors have been described to interfere with
NF-kB signaling (www.nf-kb.org). These include many natural
products first characterized to have anti-inflammatory effects or
environmental toxins. While these products have been shown to
inhibit the induction of a kB-site transcriptional reporter plas-
mid, nuclear NF-kB DNA-binding activity, and/or IKK activity,
the precise molecular targets of most of these inhibitors remain
obscure. The primary pharmacological targets of the NF-kB
activation pathway thus have been IKK and the 20S/26S protea-
some. While the former is thought to act specifically on NF-kB
(though other phosphorylation targets are being identified), the
latter clearly has highly pleiotropic effects; in the presence of
NF-kB-inducing stimulus, the effect on NF-kB may be function-
ally dominant. Other small molecules are known to act on
diverse cellular mechanisms but also show an inhibitory effect
on NF-kB. This effect may be due to a lack of molecular
specificity or may be suggestive of signaling crosstalk. Anti-
oxidants and a variety of mitogen-activated protein kinase
(MAPK) inhibitors fall into this category.
Molecular specificity of pharmacologic inhibitors does not
necessarily translate into specificity at the levels of physiolo-
gical responses or stimulus-specific gene expression pro-
grams. It appears that molecular pleiotropic drugs such as
sodium salicylate (aspirin) or PS-341 (bortezomib) can have
useful physiologically specific effects. One might argue that
partial inhibition of multiple molecular mechanisms may
result in synergistic effects on a specific subset of physiologi-
cal conditions, stimuli, or target genes. Therefore, to better
understand the mode of action of successful pharmaceuticals
and to identify further therapeutic strategies to regulate
inflammation and NF-kB-dependent immune responses,
quantitative dynamic models of the relevant signaling net-
works may prove critical.
The extent and challenge of such modeling efforts is under-
scored by the identification of a large number of cell- and
pathogen-encoded proteins that physically and/or functionally
interact with the NF-kB-signaling system (www.nf-kb.org). In
addition to many single gene publications, recent systematic
efforts by coimmunoprecipitation followed by mass spectro-
metry (45) and genome-wide yeast two hybrid approaches
(46) have resulted in a long list of potential interactions
whose functional roles remain to be explored. Interactions
between NF-kB dimers and a variety of transcription factors
[e.g. signal transducers and activators of transcription
(STATs), IFN regulatory factors (IRFs), E2Fs, fos/jun, cAMP
responsive element-binding proteins (CREB)] and coactiva-
tors/repressors [e.g. CREB-binding protein (CBP)/p300, his-
tone deacetylases (HDACs), TAFs] are likely to play a role in
stimulus- and promoter-specific transcriptional regulation.
Interactions with upstream regulators, such as MAPKs, protein
kinase A, and protein kinase C protein phosphatases, are
indicative of the wider cellular network of signaling proteins
that contribute to the regulation of NF-kB activity. In addi-
tion, a variety of pathogen-derived proteins have been shown
to interfere with NF-kB signaling. Pathogens may benefit
from downregulating NF-kB, as it may serve to evade
immune surveillance by inhibiting inflammatory gene expres-
sion, while activation may prevent infected cells from under-
going apoptosis.
Immune functions of NF-kB
NF-kB has multiple roles in the immune system, both in the
development, differentiation, and survival regulation of its
effector cells, as well as in the dynamic regulation of local
and systemic immune activity. Extensive discussions of each
aspect may be found in several previous reviews (47–49).
Below, we provide an overview of insights largely gained
from the analysis of mouse knockouts. Many of the published
and some unpublished phenotypes (A. H., X. F. Qin, D. B.)
are listed in Table 1. It is increasingly recognized that inter-
pretation of knockout phenotypes requires consideration of
the fact that while only one polypeptide is targeted by a
knockout, NF-kB is a dimeric transcription factor, and each
of the several possible dimers functions within a homeostatic
signaling network.
Lymphocyte biology
Given NF-kB’s discovery in B cells, early analysis of mouse
knockouts was focused on phenotypes in lymphocyte develop-
ment and function. Indeed, the activation domain-containing
Hoffmann & Baltimore  The NF-kB-signaling system
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proteins RelA and cRel were found to be critical for lympho-
cyte development and function. While cRel-deficient mice are
viable and exhibit normal numbers of many lymphocyte sub-
classes, mature lymphocytes exhibit a number of activation
defects, such as B- and T-cell proliferation and isotype switch-
ing (50). These defects are exacerbated in mice deficient for
both cRel and its dimerization partner p50 (51). Absence of
RelA, however, leads to embryonic lethality during embryo-
nic day E14-15, due to massive apoptosis in the fetal liver
brought about by the pro-apoptotic effects of TNF. Similarly,
apoptotic sensitivity of hematopoietic precursors prevented
the functional analysis of RelA deficiency in lymphocytes in
fetal liver transplant experiments (52), although further ana-
lysis showed that RelA deficiency only causes a partial defect
in lymphocyte proliferation (53). Further studies also indicate
that canonical NF-kB provides survival and proliferative sig-
nals to lymphocytes and survival signals downstream of pre-
TCR and pre-BCR signals, thus facilitating early B- and T-cell
development (48).
It is tempting to equate cRel function with proliferation and
RelA with pro-survival functions in lymphocytes. This model
is clearly overly simplistic, as these two proteins also have
overlapping functions in both processes. B lymphocytes defi-
cient in cRel are prone to undergo mitogen-induced apopto-
sis, presumably due to a loss in upregulation of the Bcl2
homolog A1 (54). Indeed, it remains possible that the anti-
apoptotic effects of RelA may in part be mediated by the RelA
target genes crel, nfkb1, nfkb2, and relb. However, the regulation
of these cellular processes by NF-kB transcription factors is of
relevance to human health: inappropriate upregulation of NF-
kB in B-cell lymphomas has been shown to provide essential
pro-survival signals in the context of highly proliferating cells
(55). These cells, in turn, exhibit gene expression signatures
that are characteristic of elevated cRel levels (56).
While regulatory mechanisms controlling survival and pro-
liferation may be difficult to separate, other studies have
focused on differentiation processes during hematopoiesis.
Combination knockout studies appear to have confirmed
that NF-kB RelA and cRel protein are less likely to have a
role in cell-intrinsic hematopoietic differentiation processes:
its developmental roles are in the regulation of cell survival,
proliferation, and cell-extrinsic factors present in the context
of lymphoid organs. For example, recent reports indicate that
the canonical NF-kB pathway is required in a cell-intrinsic
manner for the efficient development of unique T-cell subpo-
pulations, such as natural killer T cells (57) and CD4+CD25+
regulatory T cells (58). Their absence can cause a breakdown
of peripheral tolerance (59). NF-kB’s role in the development
of these specialized cells is likely in regulating survival,
maturation, and proliferation rather than in controlling differ-
entiation or cell fate switch.
Secondary lymphoid organ development
Lymphocyte development requires the correct functioning of
secondary lymphoid organs and their precise microarchitec-
ture. Interestingly, both RelA- and RelB-deficient mice (60,
61) are deficient in peripheral lymph nodes, as are mice
harboring p50 and p52 deficiencies (62). NF-kB activity is
also required in stromal cells for the development of splenic
microarchitectures. In fact, the developmental deficiencies in
the B- and T-cell compartments of NF-kB knockout mice
appear to be largely due to stromal, epithelial, or dendritic
cell populations in thymus and spleen that are radiation resis-
tant (63). Such deficiencies can also result in defective dele-
tion of auto-reactive T cells and establishment of central
tolerance. Interestingly, several gene knockout mouse models
defective in components of the non-canonical pathway exhibit
autoimmune symptoms and autoreactive T cells (64).
It remains unclear what the NF-kB target genes are which
are critical for secondary lymphoid organ development. NF-
kB target genes in the different cell types (stromal, dendritic,
and lymphoid) are likely to play a role. The non-canonical
signaling pathway, which is triggered by organogenic stimuli
such as lymphotoxin b and regulates RelB-containing dimers,
has been shown to activate a specific subclass of NF-kB-
dependent genes, including those encoding the organogenic
chemokines CCL21 and CXCL15 (65). As RelB is a known
target gene of canonical NF-kB, it is of interest to determine
whether RelA or p50 deficiency affects lymph node develop-
ment by altering the activation of non-canonical NF-kB
dimers. Indeed, signaling crosstalk between canonical and
non-canonical pathways and characterization of the non-
canonical gene expression program are important questions
of current research.
Inflammation and innate immunity
A prominent function of NF-kB in the immune system is the
regulation of inflammation, and much research has focused
on the molecular mechanisms involved. Inflammatory stimuli
are potent inducers of gene expression programs that are
almost entirely NF-kB dependent, as determined by micro-
array experiments with murine embryonic fibroblasts, macro-
phages, dendritic cells, or B cells (35, 36, A. H. and D. B., data
not shown). Many of these genes are also dependent on
other transcription factors and regulatory mechanisms invol-
ving chromatin or post-translational modification events.
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However, there are surprisingly few data on NF-kB’s role in
regulating inflammation during an actual immune response in
the mouse. Cell type-specific knockouts or IkB super-repressor
transgenes are likely to be instructive. Given the dependence
of inflammatory gene expression on NF-kB, such genetic tools
may also be useful in determining the role of different cell
types in providing for inflammation that may be required for
immune activation in response to different pathogens.
Recent commentaries have emphasized that the initiation of
inflammation is intricately linked to its resolution (66). This
physiological phenomenon is reflected also in the molecular
mechanisms that regulate NF-kB activity. NF-kB is subject to a
variety of negative feedback mechanisms, the most prominent
being those mediated by IkBa, the ubiquitination enzyme
A20, and more recently IkBe. Efforts to reconstruct these
mechanisms in computational models (14, 24, 67) provide
the tools to explore their overlapping and distinct functions in
attenuating NF-kB activity. In addition, stimulus-induced
degradation of promoter-bound RelA has been shown to be
an important mechanism in macrophages for controlling
inflammation, interestingly via the phosphorylation of RelA
by IKK itself (68). Thus, IKK activation may be thought of as
both inducing and limiting the activity of NF-kB.
Gene expression profiling suggests a major role of NF-kB in
innate immunity via the production of anti-microbial peptides
and serum proteins. These roles remain to be investigated in
suitable experimental settings. However, macrophage and
dendritic cell maturation and activation appear defective in
the absence of NF-kB proteins (X. F. Qin, A. H., D. B.,
unpublished observations). More thorough analyses have
revealed that activation of macrophages with TLR ligands can
lead to apoptosis in monocytic cells defective in NF-kB activa-
tion, which suggests important survival functions for NF-kB
(69). Interestingly, the NF-kB target genes responsible for
mediating survival signals in macrophages in response to LPS
are different from those required in hepatocytes or fibroblasts
in response to TNF stimulation.
Emerging specificity mechanisms
NF-kB has emerged as a central player in a variety of physio-
logical functions and in the transmission of diverse cellular
signals. How do cells achieve cell type-specific, context-
specific, and stimulus-specific responses by employing a
single signaling pathway in so many functions?
Given a large number of diverse kB-binding site sequences,
a family of NF-kB dimers, three IkB isoforms, and many
different NF-kB-inducing stimuli, one might expect that
each stimulus is capable of activating a specific gene expres-
sion program by inducing the degradation of a specific subset
of IkB proteins, leading to the release of specific subset of
dimers that is capable of binding only a subset of kB-binding
sites. Despite significant efforts to characterize specificity at
each of these mechanistic steps, little functional evidence has
been presented for specificity at the level of the interaction
between NF-kB isoforms and kB sites or between IkB iso-
forms and NF-kB isoforms; IkB isoform-specific degradation
by a particular stimulus has also not been established.
However, recent work has begun to reveal several specifi-
city mechanisms that are operating in unexpected and subtle
ways. Some of these are occurring during the NF-kB activa-
tion process, and others are occurring on gene promoters. The
former are determined by the receptors that activate specific
signaling networks, and the latter are encoded in the regula-
tory code of each NF-kB target gene.
Specificity mechanisms in the regulation of NF-kB activity
Because NF-kB is constitutively present in resting cells in a
latent form, the stimulus-responsive activation mechanisms
that render it capable of binding DNA and activating genes
comprise the first biochemical steps able to mediate stimulus-
specific gene expression. Interestingly, NF-kB activation
occurs with a stimulus-specific temporal profile. To study
temporal regulation, we constructed a mathematical model
based on differential equations that recapitulates the biochem-
ical events that control nuclear NF-kB activity in response to
TNF stimulation (14). Combined computational simulations
and experimental analysis revealed that even very short tran-
sient TNF stimulations generate a complete hour of NF-kB
activity, which is sufficient to drive the expression of many
genes; however, longer stimulation was required for sustained
activity, which is responsible for driving the expression of a
second set of genes. Indeed, mutating the negative feedback
mediated by IkBa resulted in aberrant gene expression in
response to TNF pulse stimulation. These conclusions were
further confirmed using single cell analysis (23).
In both single cell and biochemical analyses, using geneti-
cally engineered cells in which the IkBa-mediated negative
feedback is dominant, oscillations of NF-kB activity were
observed (14, 23). It is currently unclear whether such oscil-
lations have important physiological functions in gene regula-
tion or whether they are merely consequences of a potent
postinduction attenuation mechanism triggered by a very
strong, non-physiological stimulus in genetically altered cells
(70). Interestingly, recent studies have identified a mechanism
that dampens IkBa-mediated oscillations in normal cells.
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IkBe expression was found to be NF-kB responsive,
providing negative feedback for NF-kB but with a 45-min
delay (24); the resulting anti-phase regulation of IkBa and
IkBe allows for steadied NF-kB activity at late times without
diminishing the ability to quickly terminate NF-kB upon
stimulus removal.
Subsequent studies revealed that the temporal profile of
NF-kB activity is largely independent of the TNF dose (71)
but determined by the type of stimulus (72) (Fig. 4B). Using a
library of theoretical IKK profiles, computational simulations
revealed that the IKK-IkB-NF-kB-signaling module is much
more sensitive to the precise level of IKK activity at later times
than at early times, leading to the prediction that stimulus-
specific temporal profiles are likely to be generated by
mechanisms that regulate the late activity of IKK (72). A
major regulator of late IKK activity in response to TNF is the
ubiquitination regulatory enzyme A20, which forms a nega-
tive feedback loop (67, 73). Examining LPS-induced IKK
activity revealed the presence of autocrine regulation, which
amplifies the late activity and constitutes a positive feedback
loop (72) and results in stabilized NF-kB activity (74). Both
negative and positive feedback mechanisms that control the
stimulus-specific temporal profile of IKK activity were indeed
shown to be critical for stimulus-specific gene expression
(72).
The simple computational model recapitulates NF-kB acti-
vation in response to TNF- and LPS-specific IKK profiles
remarkably well, suggesting that future studies ought to
focus on the signaling pathways that emanate from each
receptor to encode stimulus-specific IKK temporal profiles.
Additional biochemical mechanisms may affect NF-kB activa-
tion in a stimulus- or cell type-specific manner. For example,
RelA is known to be specifically phosphorylated on a variety
of serines. As antibodies for specific phosphorylation events
become available, their functional roles will become clearer.
Stimulus-responsive phosphorylation, for example, has been
observed in serine 536 and has been proposed to enhance the
nuclear translocation rate of the RelA-containing dimer (75)
and to regulate specific acetylation that is correlated with
transcriptional activity (76). Phosphorylated serines may reg-
ulate DNA binding, possibly to specific kB-site sequences
and/or the interaction with IkB molecules. Cytoplasmic RelA
phosphorylation coincident with activation may also deter-
mine the ability of NF-kB to transactivate once bound to
target gene promoters by regulating the interaction with
coactivators and corepressors. Indeed, a phosphorylation
code with stimulus and target gene specificity has been pro-
posed (77).
Cytoplasmic signaling events may determine the distribution
of NF-kB dimers that are activated. For example, the non-
canonical signaling pathway is known to activate RelB-contain-
ing dimers in addition to the classical NF-kB p50 : RelA dimer
(78). In B cells, RelB activation via the non-canonical pathway
is correlated with the induction of a subset of NF-kB responsive
genes (43). Within the canonical pathway, which controls
activation of several different dimers, biochemical studies
with recombinant proteins have not resulted in convincing
evidence for interaction specificity. However, careful biochem-
ical analysis of IkB and NF-kB/Rel gene knockouts may reveal
stimulus-specific activation of subsets of dimers that play a role
in determining stimulus-specific gene expression programs. In
that regard, computational modeling of the entire NF-kB reg-
ulatory network will prove essential to understanding the
dynamic behavior of the system and its ability to generate
stimulus-specific temporal regulation of multiple dimers.
Specificity mechanisms on NF-kB-regulated promoters
Specificity in transcriptional regulation has long been
proposed to involve the combinatorial control of several tran-
scription factors. Generally, NF-kB may not be sufficient
to activate gene expression but may function together
with cooperating transcription factors and coactivators
(Fig. 5) to effect chromatin remodeling, recruitment of
general transcription factors, open initiation complex form-
ation, transcriptional initiation, and/or elongation (79). The
Fig. 5. Signaling crosstalk and combinatorial control. Stimuli that
activate NF-kB also activate other signaling pathways that may
modify the signal processing characteristics of the signaling module
(crosstalk) or that may coordinately regulate the activity of other
transcription factors to effect stimulus-specific gene expression and
cellular responses.
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ubiquitous histone acetyl transferase CBP/p300 binds RelA
via two distinct interaction domains and is recruited to
endogenous NF-kB target genes (80). However, a role in
stimulus-specific gene activation has not been described, and
recruitment can also be observed on promoters that are not
induced. In contrast, the ankyrin repeat protein Bcl3, which
is sometimes considered an IkB family member but has
coactivator activity (81), appears to function stimulus-and
promoter-specifically (82). Further studies are required to
elucidate the regulatory mechanisms involving Bcl3.
NF-kB-responsive promoters contain consensus-binding
sites for a variety of other transcription factors often clustered
into enhancers. These factors include the constitutive transcrip-
tion factor SP-1 and the inducible IRFs, STATs, ATFs, CEBPs,
CREB, and AP-1, many of which have also been shown to
interact with NF-kB directly. The enhancer of the IFN-b gene
is best understood. This enhancer requires the assembly of an
enhanceosome complex consisting of NF-kB, ATF2/c-Jun, and
IRFs to recruit histone modification enzymes, effecting the
repositioning of a core promoter nucleosome and recruitment
of TFIID (83, 84). Interestingly, each of these transcription
factors is inducible by different stimuli, but only the complete
set, induced by viral infection, allows for IFN-b gene activa-
tion. The IL-2 gene promoter was shown to be regulated by
cRel-containing dimers that effect nucleosome disassembly
from regulatory sequences (85), while other transcription
factors may regulate subsequent activation steps. Future studies
on the combinatorial control of transcription factors on pro-
moters ought to account for the dynamics by which each
transcription factor is activated. Just as NF-kB activity is tem-
porally regulated in a stimulus-specific manner, other, poten-
tially cooperating factors are likely to exhibit their own
stimulus-specific dynamics. Target promoters may require
these to be temporally coincident or present in a particular
sequence. Dynamic control of cooperating transcription factors
is therefore likely to be a critical mechanism in stimulus-
specific gene expression.
Investigating the molecular mechanism of the anti-
inflammatory effect of steroid hormones has recently turned
out to be a useful probe for stimulus- and promoter-specific
coactivator function. The hormone-bound glucocorticoid
receptor (GR) is recruited to many inflammatory promoters
by binding RelA-containing dimers, thereby disrupting RelA’s
interaction with certain coactivators. The transcription factor
IRF3, which is induced by a subset of TLRs, is an obligate
coactivator (may not require its cognate DNA-binding site)
for a subset of NF-kB-responsive promoters (86, 87).
Interestingly, many of these IRF3-dependent promoters were
found to be sensitive to repression by GR when activated by
NF-kB-inducing stimuli (88). Similarly, the transcriptional
elongation factor P-TEFb (an RNA polymerase CTD Ser2
kinase) was shown to be recruited upon cell stimulation to
the NF-kB-responsive promoter of the IL-8 gene but not to
the IkBa promoter. This coactivator requirement sensitizes
the IL-8 gene to glucocorticoid-mediated inhibition (89).
Whether a promoter requires a particular coactivator is deter-
mined by the promoter sequence, and as discussed below,
that information may be encoded in the kB-site sequence
itself.
Specificity mediated by NF-kB dimer isoforms
The fact that NF-kB comprises a family of homologous but
different transcription factors suggests that specificity in the
pathway may be achieved through their promoter-specific
functions. As reviewed above, phenotypes of single and com-
bination gene knockout mice indicate specific and overlapping
molecular functions of the NF-kB proteins (47). A compre-
hensive comparison of single and double NF-kB knockouts
with a panel of knockout murine embryonic fibroblasts did
indeed reveal promoter-specific requirements for specific NF-
kB proteins (90). In the case of the pro-inflammatory IL-12
p40 gene, whose induction in macrophages is largely cRel-
dependent (91), the functional kB-site sequence exhibited
lower affinity for RelA dimers than for cRel dimers, whose
sequence preference appears to be broader (92). A similar
working model of broader specificity for RelB-containing
dimers is suggested by the observation that these dimers
are able to activate promoters with unusual kB-site sequences
(in addition to consensus sites) that are not bound by RelA
dimers (65).
However, attempts to elucidate a general specificity code
for NF-kB dimers vis-a`-vis kB-site sequences have failed so far,
both biochemically and genetically. In the comprehensive
knockout study, the gene-specific requirement for specific
NF-kB dimers did not neatly correlate with the specific
sequence of the kB site (90), suggesting that other factors,
most probably cooperating transcription factors, play a role in
defining the specific NF-kB dimer requirement. Two addi-
tional observations support this view. First, promoters that are
not activated by a specific NF-kB dimer may still show recruit-
ment of the dimer, as determined by ChIP. Second, the spe-
cific dimer requirement of a gene was found to be stimulus-
specific, i.e. the restriction imposed by a kB site for a subset of
dimers pertains to one stimulus; it may be overcome by the
coactivator or cooperating transcription factor induced by a
second stimulus (82).
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Despite the apparent involvement of cooperating factors,
the stimulus specificity of two tandem kB sites was found to
be transferable to a heterologous promoter. Interestingly,
many NF-kB responsive promoters appear to have such a
‘tandem kB site specificity module’ that may functionally act
like enhancer elements. By swapping kB sites from two such
modules with differing NF-kB dimer specificities, it is possi-
ble to determine a code that is dependent on stimulus and cell
type. Initial studies, focused on the ability to be activated by a
RelA homodimer, revealed that specific kB-site sequences can
be classified as being either restrictive (not allowing activa-
tion), permissive, or mediating the restriction when paired
with a restrictive site (Fig. 6). These studies also suggested that
the kB-site sequence determines the interaction repertoire of
the bound NF-kB dimer with potential coactivators. In the
case of the tandem kB site-specificity modules of the IP-10
and MCP-1 chemokine genes, a single base pair in the kB-site
sequence appears to confer the requirement for the Bcl3
coactivator to allow for TNF-induced gene expression
(Fig. 6). Transcription factor allostery affected by different
binding sites has previously been proposed to account for
functional specificity of the nuclear hormone transcription
factors (93). In the case of NF-kB, an early comparison of
NF-kB dimer bound to two different kB-site sequences
revealed structural differences that correlated with functional
differences (17).
These initial studies indicate that while the kB-site code
is complex and determined at multiple levels of molecular
interactions, genetic approaches complemented by extensive
structural and biophysical studies will probably yield the
important molecular mechanisms that determine the specifi-
city of NF-kB regulation of gene expression. In addition,
however, it is becoming clear that these mechanisms are
operating in a dynamic manner. Early studies suggested that
a p50 : p50 homodimer bound constitutively to the IFN-b
promoter may give way to a p50 : RelA dimer upon cellular
activation. More recently, time course studies by ChIP of
NF–kB protein association with endogenous promoters
revealed that the same promoter may be sampled by several
different NF-kB dimers in a sequential manner following the
activation. In particular, RelA-containing dimers initially
(within 30 min) recruited to responsive promoters may be
replaced at later times (during the second hour) by RelB-
containing dimers, which are not susceptible to IkBa negative
feedback inhibition. However, the functional consequence of
this dynamic exchange remains unclear and may indeed be
gene specific, as an RelB deficiency results in both decreases
and increases in gene expression levels (A. H. and D. B.,
unpublished data). Transient association of RelA with promo-
ters can in fact be regulated by proteasomal degradation that is
critical in macrophages for limiting inflammatory responses.
Interestingly, RelA phosphorylation of a specific serine by
IKKa marks RelA for proteolysis (68). These observations
emphasize the need to consider the dynamics of signaling
by the family of NFkB dimers when studying the molecular
mechanisms of NF-kB physiological function.
Conclusion
NF-kB plays a central role in inflammation and in innate immu-
nity by regulating the expression of numerous cytokines and
chemokines, cell surface receptors, and adhesion molecules. By
regulating the molecules that allow cells to communicate with
each other, NF-kB plays a central role in the coordination of the
multipronged pathogen-specific human immune response that
culminates in development of adaptive immunity.
Extensive research efforts have already been devoted to
describing NF-kB’s role in many physiological and patho-
logical processes. However, there is much more to learn.
Given that NF-kB is so central and already a target of interest
to the pharmaceutical industry, it is important to learn as
A B
Fig. 6. Toward a nuclear factor (NF)-kB dimer specificity code. (A)
Two tandem kB sites are required for the expression of several NF-kB-
responsive genes, and they are sufficient to confer a specific NF-kB dimer
requirement to a heterologous promoter (82). Tandem combinations of
kB sites derived from the MCP-1 or the IP-10 promoter (M1 and M2, and
I1 and I2, respectively) show differential abilities to mediate gene acti-
vation by RelA homodimers (HOM) or only p50:RelA heterodimers
(HET). (B) The above data suggest that each kB site within the tandem
kB site specificity module can be classified as either imposing specificity
for HETs (S ¼ specific), allowing for homodimers function
(P ¼ permissive), or for mediating specificity imposed by an S site but
not imposing it itself (M ¼ mediating). As a result, a Boolean system of
the three classes of kB sites can be constructed to specify whether a given
promoter is permissive to the RelA:RelA homodimers (P) or specific for
the p50:RelA HET (S).
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much as possible about its range of activities as a guide to
developing agents that can affect some but not all of its
activities. Important avenues in this regard are characterizing
the accessory signaling pathways that impart specificity and
the subtle biochemical but functionally relevant differences of
isoforms within the NF-kB dimer family, the family of possi-
ble kB-site sequences, the IkB family, and the IKK family.
Recent advances suggest that combining detailed genetic and
biophysical studies will yield unexpected insights into the
mechanisms that impart specificity.
Because the NF-kB activation process as well as its accessory
signaling mechanisms are highly dynamic, mechanistic
insights from genetic and biophysical studies ought to inform
computational models. Recent advances already demonstrate
that specificity in signaling can be imparted by dynamic con-
trol, suggesting that dynamic simulations with mathematical
models are likely to provide important insights into specificity
mechanism and to lead to identification of pharmacologic
strategies that have stimulus-specific effects. In the longer
term, in silico reconstruction of the NF-kB-signaling system
and the molecular regulatory systems in which it is embedded
will be critical to understanding how specific physiological
signals not only control cellular behavior but also to the
multiorgan process of immune development and immune
function.
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